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Vertebrate oocytes actively contribute to follicle development by secreting a variety of 22 
growth factors, among which bone morphogenetic protein 15 (BMP15/Bmp15) and 23 
growth differentiation factor 9 (GDF9/Gdf9) have been paid particular attention. In the 24 
present study, we describe the cellular localization, the developmental profiles, and the 25 
response to unilateral ovariectomy (a procedure implying the surgical removal of one of 26 
the ovaries) of protein and mRNA steady-state levels of Bmp15 and Gdf9 in the ovary 27 
of European sea bass, an important fish species for marine aquaculture industry. In situ 28 
hybridization and immunohistochemistry demonstrated that the oocyte is the main 29 
production site of Bmp15 and Gdf9 in European sea bass ovary. During oocyte 30 
development, Bmp15 protein expression started to be detected only from the lipid 31 
vesicle stage onwards but not in primary pre-vitellogenic (i.e. perinucleolar) oocytes as 32 
the bmp15 mRNA already did. Gdf9 protein and gdf9 mRNA expression were both 33 
detected in primary perinucleolar oocytes and followed similar decreasing patterns 34 
thereafter. Unilateral ovariectomy induced a full compensatory growth of the remaining 35 
ovary in the 2-month period following surgery (Á. García-López, M.I. Sánchez-Amaya, 36 
C.R. Tyler, F. Prat 2011). The compensatory growth elicited different changes in the 37 
expression levels of mRNA and protein of both factors, although the involvement of 38 
Bmp15 and Gdf9 in the regulatory network orchestrating such process remains unclear 39 
at present. Altogether, our results establish a solid base for further studies focused on 40 
elucidating the specific functions of Bmp15 and Gdf9 during primary and secondary 41 
oocyte growth in European sea bass.  42 
 43 





1. Introduction 47 
It is widely accepted that growth factors locally produced within the ovary play 48 
essential roles in controlling the development of vertebrate oocytes [19,23,24,31]. Some 49 
of these factors are produced early during oocyte development, regulating follicular 50 
growth in a gonadotropin-independent manner, and/or at later stages contributing to 51 
oocyte growth by modulating or mediating several gonadotropin activities within the 52 
follicle [19,23,24,31]. 53 
Among mammalian oocyte-derived growth factors, two members of the transforming 54 
growth factor, beta (TGFB) superfamily, namely bone morphogenetic protein 15 55 
(BMP15) and growth differentiation factor 9 (GDF9), have received particular attention 56 
and numerous studies have demonstrated their essential roles in regulating ovarian 57 
follicular functions and development. In vitro treatment with BMP15 or GDF9 has been 58 
shown to enhance oocyte developmental competence [24] and to promote granulosa and 59 
theca cells proliferation together with a reduction of follicular steroidogenesis 60 
[14,43,50]. Moreover, complete neutralization of BMP15 or GDF9 results in a 61 
disruption of follicular growth from a very early stage of development, while partial 62 
neutralization leads to enhanced ovulation rates probably as a consequence of an 63 
increased sensitivity to follicle stimulating hormone (FSH; [29,30,40]). The use of 64 
‘knock-out’ mice models has also shown that BMP15 regulates the fertilization 65 
potential of oocytes, while GDF9 is essential for normal follicular development 66 
[6,12,53]. 67 
As observed for mammals, the oocyte seems to be the primary expression site of 68 
bmp15/Bmp15 and gdf9/Gdf9 mRNAs and proteins in teleost fish [4,7,32-34]. Even 69 
though mRNA expression profiles during follicular development suggest the 70 
involvement of both factors in early oogenesis stages in fish [22,32-34], experimental 71 
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evidence supporting this idea is lacking at present. Nevertheless, results of in vitro 72 
assays using zebrafish follicles suggest that Bmp15 plays a role in promoting secondary 73 
follicle growth while suppressing precocious oocyte maturation [7,8], whereas Gdf9 has 74 
been reported to modulate transcript abundance of tight junction complex components 75 
and steroidogenic acute regulatory protein [10]. 76 
Ligands of the TGFB superfamily in mammals are translated as pre-propeptide 77 
precursors consisting of an N-terminal signal peptide followed by a prodomain and a 78 
mature domain [6]. The biologically active form is obtained after dimerization of the 79 
protein precursor and cleavage of the mature peptide domain in homo-dimeric form [6]. 80 
After proteolytic cleavage, however, the prodomains of many TGFB ligands remain 81 
non-covalently associated in a complex with their mature domains; such association 82 
modulates the access of the peptides to their cognate receptors, even totally preventing 83 
the ligand-receptor interactions [11]. Dissociation of these complexes is tightly 84 
regulated by extrinsic biological processes, ensuring that the active mature ligand is 85 
only released at a location and at a moment where it is required [11,55]. Based on 86 
structural-sequence homologies, it is assumed that piscine Bmp15 and Gdf9 are 87 
similarly processed as their mammalian counterparts. Nevertheless, the expression of a 88 
homo-dimer has been only reported for zebrafish Bmp15 oocytes artificially over-89 
expressing the bmp15 gene [8]. 90 
Recently, we cloned the full cDNA sequences encoding bmp15 and gdf9 in European 91 
sea bass (Dicentrarchus labrax), one of the most important commercial marine fish 92 
species in the Mediterranean area, and found both transcripts highly expressed during 93 
early ovarian development [22]. In this study, European sea bass specific Bmp15 and 94 
Gdf9 anti-sera were produced in order to quantify protein levels throughout the annual 95 
ovarian development cycle as well as in isolated follicles at different developmental 96 
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stages. mRNA and protein expression sites for both factors were furthermore localized 97 
in the ovary by in situ hybridization and immunohistochemistry, respectively. Finally, 98 
the changes in ovarian mRNA and protein levels of both factors in response to unilateral 99 
ovariectomy (ULO), a surgical procedure implying the removal of one the gonads [17], 100 
were analyzed in order to evaluate a potential involvement of Bmp15 and Gdf9 in the 101 
growth compensation observed in the remaining ovary. 102 
 103 
2. Material and Methods 104 
2.1. Fish handling 105 
All experimental procedures involving care and use of live animals were carried out 106 
according to Spanish national and European bioethical regulations and were approved 107 
by the CSIC Bioethical Committees. Prior to every sampling, fish were sedated with 2-108 
phenoxyethanol at a 300 ppm dose in order to reduce handling stress. For euthanasia, 109 
the double anaesthetic dose was applied followed by decapitation of the fish. 110 
 111 
2.2. Anti-serum production 112 
For polyclonal anti-serum production, recombinant European sea bass Bmp15 and Gdf9 113 
peptides were produced in Escherichia coli BL21(DE3) cells (Novagen; Madison, WI, 114 
USA) transfected with the pBiEx-1 expression vector (Novagen) containing the cDNA 115 
sequences encoding the respective mature peptides (amino acids 303-459 for bmp15; 116 
amino acids 305-438 for gdf9; [22]). cDNA sequences were inserted in the BamHI-117 
HindIII (for Bmp15 construct) and KpnI-XhoI (for Gdf9 construct) restriction sites of 118 
pBiEx-1, allowing the resulting recombinant peptides to include a N-terminal 6× His 119 
tag. Correct arrangements of expression constructs were confirmed by DNA 120 
sequencing. Bacterial inclusion bodies (containing the peptides) were isolated using 121 
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BugBuster® reagent (Novagen) and solubilized in PBS containing 4% v/v 2-122 
mercaptoethanol. Purification of recombinant peptides was achieved by SDS-PAGE 123 
(12.5% gels; see section 2.3.) under reducing and denaturing conditions and subsequent 124 
excision of the respective protein bands from the gel. Bands were thoroughly minced, 125 
resuspended in 1mM EDTA plus complete protease inhibitor cocktail (Roche, 126 
Mannheim, Germany), and then incubated with agitation at 37ºC overnight for protein 127 
elution. Batches of eluted proteins were pooled, concentrated using Amicon ultra-15 128 
centrifugal filter devices (10 KDa MWCO membrane; Millipore; Billerica, MA, USA), 129 
and stored at -80ºC. Anti-serum production was performed by Biomedal S.L. (Seville, 130 
Spain). Specificity of peptide and anti-serum production was ascertained by Coomassie 131 
blue staining and Western blot analysis using an anti-6×His epitope tag antibody (600-132 
401-382; Rockland; Gilbertsville, PA, USA) and the specific anti-sera as described 133 
under section 2.3. 134 
 135 
2.3. SDS-PAGE and Western blot analysis 136 
Protein samples were quantified using the Pierce® BCA protein assay kit (Thermo 137 
Fisher Scientific; Waltham, MA, USA) and then submitted to electrophoresis in 4% 138 
stacking and 10-12.5% resolving polyacrylamide gels (0.1% w/v SDS) under denaturing 139 
and reducing or non-reducing conditions (10 min at 95°C in the presence or absence of 140 
4% v/v 2-mercaptoethanol, respectively). Gels were stained with 0.1% w/v Coomassie 141 
brilliant blue R-250 (Fluka; Sigma-Aldrich, Madrid, Spain) in a 40% v/v methanol and 142 
10% v/v acetic acid solution. A broad range prestained SDS-PAGE standard (Bio-Rad 143 
Laboratories; Hercules, CA, USA) was used as molecular weight marker. 144 
For Western blot analysis, electrophoresed protein samples were blotted onto 0.45µm 145 
Amersham HybondTM-C Extra nitrocellulose membranes (GE Healthcare; Chalfont St. 146 
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Giles, UK). Membranes were blocked in 5% w/v non-fat milk for 60 min and then 147 
probed with anti-6×His epitope tag antibody (Rockland; 1/3,000), European sea bass 148 
Bmp15 anti-serum (1/20,000), or European sea bass Gdf9 anti-serum (1/6,000) for 60 149 
min. For signal detection, membranes were incubated with donkey anti-rabbit IgG 150 
horseradish peroxidase-linked secondary antibody (GE Healthcare, NA934; 1/5,000) for 151 
60 min using the Amersham ECL system (GE Healthcare). Finally, chemiluminescent 152 
signals were visualized and quantified using a ChemiDocTM XRS+ Molecular Imager 153 
equipped with the Image LabTM software (Bio-Rad Laboratories). 154 
 155 
2.4. Seasonal expression levels of Bmp15 and Gdf9 proteins in the ovary during the first 156 
reproductive cycle 157 
Female European sea bass, obtained from a stock raised in the facilities of the Instituto 158 
de Acuicultura Torre de la Sal (Castellón, Spain), were monthly sampled during the first 159 
sexual maturation period. At each sampling point, five fish were euthanized and their 160 
ovaries dissected. Part of the ovarian tissue was frozen in liquid nitrogen for protein 161 
extraction (see below) and part was processed for histological analyses [46].  162 
Crude protein extracts were obtained by disrupting around 100 mg ovarian tissue in 1 163 
ml of buffer containing 72 mM Tris pH 6.8, 18.2% v/v glycerol, 3.64% w/v SDS. After 164 
centrifugation (15 min, 4ºC, 12,000 ×g), supernatants were collected, the total protein 165 
content determined, and then each sample (50 µg of total protein per lane) was 166 
subjected to SDS-PAGE and Western blot analysis as described under section 2.3.  167 
 168 
2.5. Cellular localization of bmp15/Bmp15 and gdf9/Gdf9 mRNAs and proteins in the 169 
ovary 170 
In situ hybridization and immunohistochemistry were performed on 6 µm paraffin 171 
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sections obtained from 4% paraformaldehyde fixed ovarian samples collected at 172 
different developmental stages [25]. 173 
 174 
2.5.1. In situ hybridization 175 
In situ hybridization was performed as described in [41], but increasing the 176 
hybridization temperature to 50ºC. Sense and anti-sense cRNA probes were synthesized 177 
by in vitro transcription of European sea bass bmp15 and gdf9 cDNA sequences 178 
encoding the mature peptides (nucleotides 1041-1514 for bmp15; nucleotides 953-1357 179 
for gdf9; [22]) as reported in [41]. 180 
 181 
2.5.2. Immunohistochemistry 182 
For immunohistochemistry, sections were first submitted to an antigen retrieval 183 
treatment with 10 mM sodium citrate pH 6.0, 0.05% v/v Tween 20 at 95ºC for 20 min 184 
(only performed for Gdf9 detection). Then, slides were incubated with 0.35% v/v 185 
hydrogen peroxide for 15 min for endogenous peroxidase blocking, treated with 3% w/v 186 
bovine serum albumin for 60 min, and probed overnight with European sea bass Bmp15 187 
anti-serum (1/500), European sea bass Gdf9 anti-serum (1/2,000) or pre-immune sera 188 
(at the same respective dilutions). For signal detection, sections were incubated with 189 
goat anti-rabbit IgG horseradish peroxidase-conjugated secondary antibody (Sigma-190 
Aldrich; A9169; 1/1,000) for 120 min and thereafter with 1.4 mM 3,3’-191 




2.6. Developmental expression levels of bmp15/Bmp15 and gdf9/Gdf9 mRNAs and 194 
proteins in isolated follicular stages and ovulated oocytes 195 
 196 
2.6.1. Isolation of ovarian follicles and ovulated oocytes 197 
Ovarian follicles were collected from vitellogenic females in December. At this time, 198 
European sea bass ovaries contain great numbers of follicles at all developmental stages 199 
from primary growth to late vitellogenesis (see below) and hence, ensure sufficient 200 
sampling material. After dissection, ovaries were quickly split in small pieces, 201 
submerged in Allprotect™ Tissue Reagent (Qiagen; Hilden, Germany), and stored at 202 
4ºC. Ovary pieces were then carefully transferred to a culture dish and follicles were 203 
manually isolated with watchmaker´s forceps under a dissecting microscope equipped 204 
with an ocular micrometer. Follicles were classified into 5 stages according to size and 205 
cytoplasm appearance [36,49]): (1) primary growth (Pg) stage consisting of chromatin 206 
nucleolar and perinucleolar follicles with a diameter lower than 120 µm; (2) lipid 207 
vesicles stage (Lv) follicles with a diameter between 120 and 250 µm; (3) early 208 
vitellogenic (Evit) follicles with a diameter between 250 and 400 µm; (4) mid 209 
vitellogenic (Mvit) follicles with a diameter from 400 to 600 µm of diameter; and (5) 210 
late vitellogenic (Lvit) follicles with a diameter between 600 and 800 µm. Ovulated 211 
oocytes (Ov) were furthermore collected from spawning European sea bass females in 212 
March and stored in Allprotect™ Tissue Reagent at 4ºC until further subsampling. 213 
Three different pools each one containing around 100-150 follicles/oocytes were 214 
collected and processed for mRNA and protein expression analyses. 215 
 216 
2.6.2. mRNA expression analysis 217 
Total RNA was extracted from isolated follicles/oocytes pools using the NucleoSpin® 218 
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RNA XS kit (Macherey-Nagel, Düren, Germany) following the manufacturer’s 219 
instructions (including an on-column DNase digestion) and further processed for 220 
quantifying gdf9 and bmp15 mRNA levels by real-time PCR as reported [18]. For 221 
bmp15 analysis the primers GGCAGATTTGATGGGTCATT (forward) and 222 
CTTTAACAGGAACGGCGAAG (reverse) were used at 100 nM (amplicon size 117 223 
bp), while for gdf9 analysis the primers TCACAGGTGGACTCTTTCCA (forward) and 224 
GCTGCTCCAGATCAAACTTCTT (reverse) were used at 200 nM (amplicon size 104 225 
bp). In addition, expression levels of the endogenous reference genes 18S ribosomal 226 
RNA (18s) and elongation factor 1-alpha (ef1a) were measured as described [18]. The 227 
relative amount of each transcript in every sample was determined using the relative 228 
standard curve method as reported [18]; as standard, serially diluted cDNA was used 229 
that had been prepared from a pool of total RNA of different follicle/oocyte stages [18]. 230 
 231 
2.6.3. Protein expression analysis 232 
To ensure sufficient protein amounts from each stage for Western blot analysis, the 233 
ethanolic lysates obtained from total RNA extraction of the different follicle/oocyte 234 
pools were combined resulting in only one pooled sample per stage of development. 235 
Samples were first submitted to diafiltration against a buffer containing 100 mM Tris 236 
pH 6.8, 0.3% w/v SDS using Amicon ultra-15 centrifugal filter devices. Subsequently, 237 
the buffer was exchanged for 100 mM Tris pH 6.8, 0.3% w/v SDS, 10% v/v glycerol, 238 
the supernatants obtained by centrifugation (15 min, 4ºC, 12,000 ×g) collected and the 239 
total protein content determined. SDS-PAGE and Western blot were performed as 240 
described under section 2.3. except different total protein loads per lane (2-50 µg) were 241 
used due to differences in total protein yield from follicles/oocytes at each 242 
developmental stage. Relative protein expression levels were obtained by correcting 243 
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band intensities by the respective protein load. 244 
 245 
2.7. Expression of bmp15/Bmp15 and gdf9/Gdf9 mRNAs and proteins in the ovary of 246 
European sea bass in response to ULO 247 
The changes in ovarian mRNA and protein levels of both factors in response to ULO 248 
was analyzed in order to evaluate a potential involvement of Bmp15 and Gdf9 in the 249 
growth compensation observed in the remaining ovary [17]. On 6th October 2009 (day 250 
0), i.e. one month before the expected onset of vitellogenesis [45], randomly selected 251 
pit-tagged adult female European sea bass (mean total body weight: 1.77±0.09 kg) were 252 
either submitted to ULO operation (n=8; ULO group), sham operated (n=4; SHAM 253 
group), or euthanized (n=5; INITIAL control group) as described [17]. Both ovarian 254 
lobes were excised from euthanized fish in the INITIAL group. Sixty nine days after 255 
operations, on 14th December 2009, females in the ULO and SHAM groups were 256 
euthanized and the ovarian lobes dissected. Part of the ovarian tissue was frozen in 257 
liquid nitrogen for protein and RNA extraction and part was processed for histological 258 
analysis as described [17]. 259 
The starting point was chosen in accordance to results in rainbow trout showing that the 260 
mid vitellogenesis was the critical developmental stage for inducing a new recruitment 261 
of primary oocytes in the remaining ovarian lobe after ULO [52]. The end point of the 262 
experiment was chosen in accordance to the vitellogenic growth period in European sea 263 
bass [45], i.e. and at the time when most of the oocytes of the first main egg clutch are 264 
expected to have reached the mid-late vitellogenesis stage [2,37]. 265 
Ovarian expression levels of bmp15 and gdf9 mRNAs in response to ULO were 266 
determined by real-time quantitative PCR as reported in [18] and using the primer pairs 267 
specified under section 2.6.2. In addition, expression levels of the endogenous reference 268 
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genes 18s and ef1a were measured as described [18]. 269 
Quantification of Bmp15 and Gdf9 protein levels in the ovary was performed as 270 
described under sections 2.3. and 2.4. 271 
 272 
2.8. Protein/gene expression data normalization, representation and statistical analyses 273 
For normalization of gene expression data, two endogenous reference genes previously 274 
used in European sea bass tissues were considered: 18s and ef1a (e.g. [3,47]). However, 275 
and even though identical RNA amounts and cDNA synthesis procedures were 276 
meticulously used for every sample analyzed none of them showed a constitutive 277 
expression in the sample sets analyzed (Supplementary Fig. 1). In addition, other 278 
common reference genes, like bactin or 28S ribosomal RNA, have already been proved 279 
not to be suitable for their use in European sea bass ovarian samples [22]. Thus, we 280 
decided to use non-normalized relative transcript amounts for the target genes studied as 281 
recently reported [17,18]. This strategy is supported by studies showing opposite trends 282 
between normalized and non-normalized data [42], contradictory results depending on 283 
the reference gene used for the same data set [56], as well as the validity of non-284 
normalized expression data to explain the molecular changes associated with 285 
oocyte/ovarian development in teleost fish [22,26]. Following the same rationale, 286 
protein expression levels were not normalized to any housekeeping reference protein, 287 
but only corrected in respect to total protein load.  288 
Protein and gene expression levels are reported as fold change in respect to the values of 289 
a selected data group, whose average value was set to 1. 290 
All the numeric data are expressed as mean ± standard error of mean (SEM). Significant 291 
differences between groups were identified by one-way ANOVA followed by the 292 
Student-Newman-Keuls test or by two-way ANOVA followed by the Bonferroni post 293 
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test. All statistical analyses were carried out adopting a significance level (p) of 0.05. 294 
 295 
3. Results 296 
3.1. Recombinant peptide production, anti-serum development, and validation of a 297 
Western blot procedure 298 
Bmp15 and Gdf9 recombinant peptides showed relative molecular weights of 32 KDa 299 
and 28 KDa, respectively (Fig. 1A). In Western blots, both peptides were labelled with 300 
an anti-6×His epitope tag antibody as well as with the respective specific anti-sera (Fig. 301 
1A). In addition, Bmp15 and Gdf9 anti-sera bound to secondary products with 302 
approximate double molecular weights (Fig. 1A), which are thought to correspond to 303 
aggregates of the main peptide forms. 304 
Western blots using European sea bass ovarian extracts, both under reducing and non-305 
reducing conditions, retrieved single protein bands of approximately 52 KDa for Bmp15 306 
anti-serum and 54 KDa for Gdf9 anti-serum (Fig. 1B), while no specific signals were 307 
obtained when extracts were probed with the pre-immune sera (not shown). 308 
 309 
3.2. Ovarian expression levels of Bmp15 and Gdf9 proteins during the first reproductive 310 
cycle 311 
Bmp15 protein was not detected at pre-vitellogenesis, but was evident at the transition 312 
to vitellogenesis (i.e. in November) (Fig. 2A). Thereafter, Bmp15 protein levels 313 
remained high at the peak of vitellogenic period (i.e. in December), decreased as late 314 
vitellogenesis, maturation-ovulation and post-spawning proceeded (i.e. from January to 315 
April), and finally reached undetectable levels at late post-spawning/pre-vitellogenesis 316 
(i.e. in May). 317 
Gdf9 protein levels were high during pre-vitellogenesis (i.e. from July to October), but 318 
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decreased significantly with the progression of vitellogenesis until January, when Gdf9 319 
protein remained undetectable (Fig. 2B). At maturation-ovulation (i.e. from February to 320 
April), Gdf9 protein levels remained low/undetectable but increased again during late 321 
post-spawning and pre-vitellogenesis (i.e. from May to June). 322 
Representative histological sections of ovarian development during European sea bass 323 
reproductive cycle are shown in Supplementary Fig. 2. 324 
 325 
3.3. Cellular localization of bmp15/Bmp15 and gdf9/Gdf9 mRNAs and proteins in the 326 
ovary 327 
When European sea bass ovarian sections were hybridized with a bmp15 anti-sense 328 
probe, positive signals were exclusively found in the cytoplasm of oocytes (Fig. 3A). 329 
The staining intensity was maximal at the perinucleolar stage and decreased steadily as 330 
oocyte development progressed with hardly detectable signals at mid-late vitellogenesis. 331 
Bmp15 protein was not detected at the perinucleolar stage, slightly appeared in the 332 
cytoplasm of lipid vesicles stage-1 oocytes and reached maximum staining intensity in 333 
oocytes at lipid vesicles stage-2 (Fig. 3B). Thereafter, signal amounts decreased in early 334 
vitellogenic oocytes being hardly detectable at mid to late vitellogenesis. No signals 335 
were detected in the follicular cells. 336 
The cellular expression patterns of gdf9 mRNA (Fig. 3C) and Gdf9 protein (Fig. 3D) 337 
were similar to that described above for bmp15 mRNA, although in case of Gdf9 338 
protein, the decrease in the signal intensity from perinucleolar to early vitellogenic 339 
oocytes was not so evident. No gdf9/Gdf9 signals were detected in the follicular cells. 340 
In no case, unspecific labelling was observed when the respective sense probe or pre-341 




3.4. Developmental expression levels of bmp15/Bmp15 and gdf9/Gdf9 mRNAs and 344 
proteins in isolated follicular stages and ovulated oocytes 345 
Bmp15 protein levels were low in follicles at the perinucleolar stage (primary growth), 346 
sharply increased at the lipid vesicles stage, and decreased progressively during 347 
vitellogenesis (Fig. 4A). mRNA levels of bmp15 (Fig. 4A) and gdf9/Gdf9 protein and 348 
mRNA amounts (Fig. 4B) followed approximately similar profiles during 349 
folliculogenesis with high expression levels in perinucleolar primary oocytes and 350 
progressively decreasing amounts in follicles from the lipid vesicles stage to late 351 
vitellogenesis. 352 
Ovulated oocytes expressed significantly lower amounts of mRNAs for both factors 353 
than late vitellogenic follicles, while the levels of the respective proteins were 354 
approximately similar in both stages (Fig. 4). 355 
 356 
3.5. Expression of bmp15/Bmp15 and gdf9/Gdf9 mRNAs and proteins in the ovary of 357 
European sea bass in response to ULO 358 
There were no significant differences in the mRNA and protein expression levels of 359 
both factors between INITIAL control and ULO females at day 0 (Fig. 5). At 69 days 360 
after surgery, transcript levels for bmp15 and gdf9 were significantly reduced 361 
(approximately 1.5- and 1.6-fold, respectively) in ULO females compared to the SHAM 362 
control group. There were no significant differences for Bmp15 and Gdf9 ovarian 363 
protein levels between treatments. 364 
 365 
4. Discussion 366 
Follicular development has been historically regarded as being passively regulated by 367 
endocrine (mainly pituitary gonadotropins) and follicular somatic cell derived hormones 368 
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(particularly sex steroids and peptide growth factors); nevertheless it is now well known 369 
that mammalian oocytes actively secrete a variety of growth factors with essential 370 
functions in this process [20]. Although experimental information is lacking for most if 371 
not all teleost species, the recent identification and description of the expression patterns 372 
within the piscine ovary of several oocyte-derived growth factors with essential roles in 373 
mammalian folliculogenesis, such as Bmp15, Gdf9 or epidermal growth factors, have 374 
suggested that fish oocytes participate actively in the regulation of its own development 375 
as well [9,12,19,22,51]. In order to shed more light on the potential roles of these 376 
growth factors in piscine oogenesis, we provide here information on Bmp15 and Gdf9 377 
transcript and protein levels in the ovary of European sea bass. 378 
To study the expression patterns of Bmp15 and Gdf9 proteins, specific polyclonal anti-379 
sera were developed and validated for their use in Western blots and 380 
immunohistochemistry using European sea bass ovarian samples. Single protein bands 381 
were obtained for each factor by Western blot using both reducing and non-reducing 382 
conditions and according to their sizes were attributed to Bmp15 and Gdf9 full pre-383 
propeptide precursor forms, which have predicted weights of 51.7 KDa and 50.1 KDa, 384 
respectively [22]. Similarly, Lokman et al. [34] reported the detection of the pre-385 
propeptide of Gdf9 as unique protein form in ovarian extracts of short-finned eel 386 
(Anguilla australis australis). On the other hand, three different Bmp15 protein bands, 387 
corresponding in size to the monomeric and dimeric mature domain and the precursor 388 
forms of the protein, were detected in zebrafish oocytes artificially over-expressing the 389 
bmp15 gene, while only the precursor form of Bmp15 was detected in untreated oocytes 390 
[8]. Altogether, this information suggests that the pre-propeptide precursors of Bmp15 391 
and Gdf9 are the predominant forms of both proteins in fish ovaries. The mature forms 392 
of fish Bmp15 and Gdf9, on the other hand, do not seem to be produced in a regular 393 
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manner as they are not readily detectable in ovarian/oocyte extracts under a variety of 394 
experimental conditions [this study, 8, 34]. This could be supported by observations 395 
reported in the mammalian ovary for several members of the TGFB superfamily, 396 
including BMP15, GDF8 and anti-Müllerian hormone, in which the production of 397 
mature peptides by dimerization and proteolytic cleavage of the precursors is tightly 398 
controlled in a timely and developmentally regulated manner ensuring that the active 399 
mature ligand is only present at a location and at a precise moment where it is required 400 
[11,55]. Further experimental work is required to determine if such situation applies to 401 
teleost Bmp15 and Gdf9 proteins as well (which may complicate to a great extent the 402 
detection of the mature peptides) or the lack of detection of the mature peptides is due to 403 
technical problems associated with the different polyclonal anti-sera used. 404 
In teleost fish, several studies have analyzed ovarian mRNA levels of bmp15 and gdf9 405 
during the course of follicular development. In most species, transcripts amounts of 406 
both factors are high during primary pre-vitellogenic growth, but decrease significantly 407 
with the progression of follicular development [22,32-34]. In contrast, there is little 408 
information on Bmp15 and Gdf9 protein expression levels during piscine oogenesis. 409 
Using specific anti-sera and European sea bass ovarian samples collected throughout an 410 
annual reproductive cycle and isolated follicles at different developmental stages, we 411 
found that Gdf9 protein followed similar temporal and developmental expression 412 
patterns as its transcript, with decreasing levels from primary growth and pre-413 
vitellogenesis to late vitellogenesis [22, this study]. For Bmp15 protein, on the other 414 
hand, expression in the ovary/oocyte was undetectable/low during the primary growth 415 
phase but increased sharply during the beginning of secondary growth (lipid vesicles 416 
stage), i.e. when bmp15 transcript levels began to decrease significantly [22, this study]. 417 
To our knowledge, this is the first time that bmp15 mRNA and Bmp15 protein have 418 
18 
 
been reported to follow incongruent expression profiles, as in all species studied until 419 
now, bmp15/Bmp15 mRNA and protein (as well as gdf9 and Gdf9) have been shown to 420 
possess overlapping spatiotemporal expression patterns in the ovary/oocyte (e.g., goat 421 
[48], mouse [13,16,38,39], rat [43], hen [28], zebrafish [7], or short-finned eel [34]). 422 
Our results suggest that Gdf9 may play a role during the primary oocyte growth phase 423 
as proposed previously in European sea bass [22], while Bmp15 could participate in the 424 
control of more advances stages of follicular development as suggested in zebrafish [8]. 425 
In situ hybridization and immunohistochemistry demonstrated that both bmp15/Bmp15 426 
and gdf9/Gdf9 mRNAs and proteins are exclusively expressed in European sea bass 427 
oocytes as reported for zebrafish [33], rainbow trout (Oncorhynchus mykiss) [4], short-428 
finned eel [34], human [1], mouse [13,16,38,39], rat [27,43], sheep [5], and hen [15]. 429 
The mRNAs and/or the proteins of both factors have also been detected in follicular 430 
somatic cells in some species, such as zebrafish [7,33], rainbow trout [32], goat [48], 431 
and hen [15,29], however in most cases at much lower amounts in comparison to 432 
oocytes. Taken together, this information indicates that the oocyte is the primary 433 
production site of BMP15/Bmp15 and GDF9/Gdf9 proteins in the ovary of vertebrates, 434 
including European sea bass. 435 
According to the expression patterns of Bmp15 and Gdf9 proteins during European sea 436 
bass follicular development, it seems evident that the regulatory mechanisms controlling 437 
the protein amounts of each factor in sea bass oocytes are different. The surge of Bmp15 438 
protein expression in the ovary/follicles coincides with the decrease of gdf9/Gdf9 439 
mRNA and protein amounts and with a sharp increase of follicle stimulating hormone 440 
receptor (fshr) mRNA levels during the reproductive cycle/follicular development in 441 
this species [this study,17,46]. Interestingly, the expression levels of BMP15 protein (as 442 
well as of its mRNA) increase in response to FSH treatment in mouse ovary, but are 443 
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down-regulated in both FSH receptor null and +/- gonads [54]. In contrast, neither in 444 
mouse nor in pre-vitellogenic coho salmon (Oncorhynchus kisutch) ovarian Gdf9/gdf9 445 
expression has been shown to be modulated by FSH treatment in vitro [21,35]. Finally, 446 
it has been demonstrated that mice lacking GDF9 show increased expression of bmp15 447 
mRNA compared to wild type siblings, while BMP15 null and +/- mouse ovaries 448 
exhibit normal Gdf9 transcript levels [53]. Although further specific studies must be 449 
performed for obtaining a solid conclusion, these evidences together with the expression 450 
patterns of Bmp15 and Gdf9 proteins during follicular development lead us to 451 
hypothesize that in European sea bass, Bmp15 oocyte levels could be regulated by both 452 
FSH- and Gdf9-dependent signaling, while Gdf9 oocyte levels do not seem to be 453 
modulated by FSH. 454 
Finally, we analyzed the ovarian expression levels of bmp15/Bmp15 and gdf9/Gdf9 455 
mRNAs and proteins in females subjected to ULO, a surgical procedure recently 456 
applied for the first time in European sea bass by our laboratory [17]. Removal of one of 457 
the ovarian lobes induced a full compensatory growth in the remaining lobe due to an 458 
increased number of early perinucleolar oocytes and mid to late vitellogenic follicles 459 
[17]. Results of gene expression analyses pointed towards members of the FSH-460 
dependent signaling pathway as the main players in orchestrating such an ovarian 461 
compensatory growth [17]. We report here that ovarian expression levels of bmp15 and 462 
gdf9 mRNAs were significantly down-regulated in hemi-castrated females, although 463 
such changes were not associated with the decrease in the amounts of the respective 464 
proteins. Thus, the potential involvement of both Bmp15 and Gdf9 in the compensatory 465 
ovarian growth following ULO in European sea bass remains unclear at present. Further 466 
experimental studies, for instance combining ULO with protocols directed to block 467 
Bmp15- and/or Gdf9-dependent signalling, are required to identify their specific 468 
20 
 
functions in the process. 469 
In conclusion, the results of the present study show that the oocyte is the primary 470 
production site of Bmp15 and Gdf9 in the ovary of European sea bass. bmp15 and gdf9 471 
transcripts exhibit almost identical spatial, temporal, and developmental expression 472 
profiles in the ovary; however, the disparate expression patterns of their respective 473 
proteins suggest that the mechanisms regulating the Bmp15 and Gdf9 amounts in the 474 
oocyte as well as their functions in oogenesis are different. The reduced mRNA 475 
amounts of both factors found in the ovary of hemi-castrated females were not 476 
accompanied by the decrease in their respective protein amounts and, thus, it remains 477 
unclear at present if Bmp15 and Gdf9 are involved in the regulatory network 478 
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 671 
Figure legends 672 
Figure 1. Production of recombinant European sea bass Bmp15 and Gdf9 peptides in E. 673 
coli for polyclonal anti-serum generation (A) and validation of a Western blot procedure 674 
for detecting both proteins in European sea bass ovarian samples (B). Lanes in panel A 675 
correspond to: 1, standard (12.5% reducing and denaturing gel); 2 and 3, SDS-PAGE 676 
(12.5% gel) of purified Bmp15 and Gdf9 peptides (respectively) stained with 677 
Coomassie blue; 4 and 5, Western blot of purified Bmp15 and Gdf9 peptides 678 
(respectively) probed with an anti-6× His epitope tag antibody; and, 6 and 7, Western 679 
blot of purified Bmp15 and Gdf9 peptides (respectively) probed with their specific anti-680 
sera. Black arrows depict monomeric forms of the purified peptides, while white arrows 681 
depict aggregated forms of them. Lanes in panel B correspond to: 1, standard (10% 682 
reducing and denaturing gel); 2-5, SDS-PAGE (10% gel) of ovarian extracts collected 683 
monthly on October, November, December, and January (respectively) stained with 684 
Coomassie blue; 6-9 and 10-13, Western blots of the same extracts probed with specific 685 
Bmp15 and Gdf9 anti-serum, respectively. 686 
 687 
Figure 2. Seasonal expression levels of Bmp15 (A) and Gdf9 (B) proteins in the ovary 688 
of European sea bass during the first reproductive cycle (n=5 per month). Data are 689 
expressed as fold change in respect to the mean values for April (Bmp15) or December 690 
(Gdf9), which were set at 1. For each parameter, different superscripts denote 691 




Figure 3. Cellular localization of bmp15/Bmp15 and gdf9/Gdf9 mRNAs and proteins in 694 
the ovary of European sea bass by in situ hybridization (A,C) and 695 
immunohistochemistry (B,D). Insets correspond to sections incubated with sense probes 696 
(A,C) or pre-immune sera (B,D). pn, perinucleolar; Lv1, lipid vesicles stage-1; Lv2, 697 
lipid vesicles stage-2; Evit, early vitellogenic; Mvit, mid vitellogenic; Lvit, late 698 
vitellogenic. Scale bars: 100 µm. 699 
 700 
Figure 4. Developmental expression levels of bmp15/Bmp15 (A) and gdf9/Gdf9 (B) 701 
mRNAs (n=3) and proteins (n=1) in isolated European sea bass follicles and ovulated 702 
oocytes. Pn/Pg, perinucleolar stage (primary growth); Lv, lipid vesicles stage; Evit, 703 
early vitellogenic; Mvit, mid vitellogenic; Lvit, late vitellogenic; Ov, ovulated oocytes. 704 
Data are expressed as fold change in respect to the mean values for Lvit, which were set 705 
at 1. Different superscripts denote significant differences between groups (p<0.05). 706 
 707 
Figure 5. Expression of bmp15/Bmp15 and gdf9/Gdf9 mRNAs and proteins in the 708 
ovary of European sea bass in response to unilateral ovariectomy (ULO). Data are 709 
expressed as fold change in respect to values for INITIAL females (day 0), which were 710 
set at 1. An asterisk denotes a significant difference compared to INITIAL-SHAM 711 
























Figure 5 726 
